Colt Egelston - Department of Immunology/Microbiology, Rush University Medical Center

基本信息

Career Trajectory

Bio

Colt Egelston currently works at the Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center. Colt does research in Immunology and Clinical Immunology with a focus on T cell functionality and antigen specificity in various cancer malignancies.

Research Interests

Papers共 107 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Interim Report on Engineered NK Cell Trial in Lung Cancer Refractory to Immune Checkpoint Inhibitors

Miguel A Villalona-Calero, Lei Tian, Xiaochen Li,Joycelynne M Palmer, Claudia Aceves,Hans Meisen, Catherine Cortez,Timothy W Synold,Colt Egelston, Jeffrey VanDeusen, Ivone Bruno, Lei Zhang, Eliezer Romeu-Bonilla, Omer Butt,Stephen J Forman,Michael A Caligiuri,Jianhua Yu

JCI insightno. 6 (2025)

Cited0Views0WOSBibtex

Supplementary Figure 3 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles Across Metastatic Sites in Breast Cancer

Colt A. Egelston,Weihua Guo,Diana L. Simons,Jian Ye,Christian Avalos,Shawn T. Solomon,Mary Nwangwu,Michael S. Nelson,Jiayi Tan,Eliza R. Bacon,Kena Ihle,Daniel Schmolze,Lusine Tumyan,James R. Waisman,Peter P. Lee

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 5 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles Across Metastatic Sites in Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 11 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles Across Metastatic Sites in Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 18 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles Across Metastatic Sites in Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Table 4 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles Across Metastatic Sites in Breast Cancer

crossref（2024）

Cited0Views0Bibtex

STING Signalling Compensates for Low Tumour Mutation Burden to Drive Anti-Tumour Immunity

Jiay Tan,Colt A. Egelston,Weihua Guo,Jeremy M. Stark, Peter P. Leea

EBIOMEDICINE（2024）

Cited3Views0WOSBibtex

Oncolytic Virus CF33-hNIS for the Treatment of Advanced Cancer

Daneng Li,Anthony F. Shields,Hirva Mamdani, Patrick Travis, Gavin Wright,Wallace Akerley,Alex Spira,Gregory Daniels,Jaime Merchan,Abhijeet Kumar,Emerson Lim,Colt Egelston, Oscar Flores,Stanley Hamilton, Janet Austria,Amanda Seiz,Sharon Yavrom,Seymour Fein,John Byon,Paul Woodard,Grey A. Wilkinson, Jennifer Leddon

CANCER RESEARCH（2024）

Cited0Views0Bibtex

Oncolytic Virus CF33-hNIS Monotherapy for the Treatment of Gastrointestinal (GI) Malignancies

Daneng Li,Anthony F. Shields,Hirva Mamdani,Jennifer Leddon,Patrick M. Travis,Colt A. Egelston, Oscar Colunga Flores,Stanley R. Hamilton, Janet Austria,Amanda Seiz,Sharon Yavrom,John Chong Han Byon, Paul,Grey A. Wilkinson

Journal of Clinical Oncologyno. 3_suppl (2024): 749-749

Cited0Views0Bibtex

Supplementary Table 3 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles Across Metastatic Sites in Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn